作者：
Joan E M,van der Lubbe [1]
;
Sietske K,Rosendahl Huber [2]
;
Aneesh,Vijayan [2]
;
Liesbeth,Dekking [2]
;
Ella,van Huizen [2]
;
Jessica,Vreugdenhil [2]
;
Ying,Choi [2]
;
Miranda R M,Baert [2]
;
Karin,Feddes-de Boer [2]
;
Ana,Izquierdo Gil [2]
;
Marjolein,van Heerden [3]
;
Tim J,Dalebout [4]
;
Sebenzile K,Myeni [4]
;
Marjolein,Kikkert [4]
;
Eric J,Snijder [4]
;
Leon,de Waal [5]
;
Koert J,Stittelaar [6]
;
Jeroen T B M,Tolboom [2]
;
Jan,Serroyen [2]
;
Leacky,Muchene [2]
;
Leslie,van der Fits [2]
;
Lucy,Rutten [2]
;
Johannes P M,Langedijk [2]
;
Dan H,Barouch [7]
;
Hanneke,Schuitemaker [2]
;
Roland C,Zahn [2]
;
Frank,Wegmann [2]
作者单位：
Janssen Vaccines & Prevention B.V., Leiden, The Netherlands. Jvander7@its.jnj.com.
[1]
Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
[2]
Janssen Non-Clinical Safety B.V., Beerse, Belgium.
[3]
Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
[4]
Viroclinics Biosciences B.V., Viroclinics Xplore, Schaijk, The Netherlands.
[5]
Wageningen Bioveterinary Research, Lelystad, The Netherlands.
[6]
Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
[7]
DOI
10.1038/s41541-021-00301-y
PMID
33741993
发布时间
2024-08-08
换一批
换一批
